April 30, 2014 / 11:14 AM / 3 years ago

Jean Coutu profit rises on higher generic drug sales

1 Min Read

Jean Coutu Group (PJC) Inc. Chairman Jean Coutu speaks during their annual general meeting in Longueuil, Quebec, July 5, 2011.Christinne Muschi

(Reuters) - Canadian pharmacy chain Jean Coutu Group Inc (PJCa.TO) reported an 8 percent rise in fourth-quarter profit, helped by higher sales at its Pro Doc generic drug outlets.

Total sales rose marginally to C$685.4 million ($625 million) in the fourth quarter ended March 31.

Net profit rose to C$57.7 million, or 30 Canadian cents per share, from C$53.5 million, or 25 Canadian cents per share, a year earlier.

($1 = 1.0966 Canadian Dollars)

Reporting By Sneha Banerjee in Bangalore; Editing by Don Sebastian

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below